Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 23c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.12 -1.23%
Revenue Growth %: -23.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -23.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of $0.06, $0.23 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $93.97 million versus the consensus estimate of $60.48 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran Has Resumed Producing Ballistic Missiles, U.S. and Middle East Officials Say - WSJ
- Gentherm shareholders back Modine unit merger, close set for Oct. 1
- OpenAI debuts ChatGPT for financial services with GPT-6 Astra
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
